Statins are associated with reduced risk of gastric cancer: A meta-analysis

European Journal of Clinical Pharmacology

Volumn 69, Issue 10, 2013, Pages 1855-1860

  Wu, Xiao Dan ^a   Zeng, Kai ^a   Xue, Fang Qin ^a   Chen, Jin Hua ^b   Chen, Yan Qing ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Gastric cancer; Meta analysis; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CANCER RISK; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG UTILIZATION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK REDUCTION; STOMACH CANCER; SYSTEMATIC REVIEW;

DRUG UTILIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS;

EID: 84884813187     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1547-z     Document Type: Article

References (54)

1. Maron DJ, Fazio S, Linton MF (2000) Current perspectives on statins. Circulation 101:207-213
2. Hebert PR, Gaziano JM, Chan KS, Hennekens CH (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278:313-321
3. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267-1278
4. Newman TB, Hulley SB (1996) Carcinogenicity of lipid-lowering drugs. JAMA 275:55-60
5. Wong WW, Dimitroulakos J, Minden MD, Penn LZ (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:508-519
6. Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C (2012) Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 7:e29849
7. Hippisley-Cox J, Coupland C (2010) Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 340:c2197
8. Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J (2010) Incidence of cancer and statin usage - record linkage study. Int J Cancer 126:279-284
9. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (2006) Statins and cancer risk: a meta-analysis. JAMA 295:74-80
10. Kuoppala J, Lamminpaa A, Pukkala E (2008) Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 44:2122-2132
11. Undela K, Srikanth V, Bansal D (2012) Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat 135:261-269
12. Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C (2013) Statins and the risk of lung cancer: a meta-analysis. PLoS One 8:e57349
13. Zhang X-l, Geng J, Zhang X-p, Peng B, Che J-p, Yan Y, Wang G-c, Xia S-q, Wu Y, Zheng J-h (2013) Statin use and risk of bladder cancer: a meta-analysis. Cancer Causes Control 24:769-776
14. Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, Shi M, Li W, Zheng H, Jiang B (2012) Statin use and risk of pancreatic cancer: a meta-analysis. Cancer Causes Control 23:1099-1111
15. Bonovas S, Nikolopoulos G, Filioussi K, Peponi E, Bagos P, Sitaras NM (2010) Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol 25:29-35
16. Bansal D, Undela K, D'Cruz S, Schifano F (2012) Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS One 7:e46691
17. Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (2013) Statins are associated with reduced risk of esophageal cancer, particularly in patients with barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:620-629
18. Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G (2012) Statins and primary liver cancer: a meta-analysis of observational studies. Eur J Cancer Prev 22:229-234
19. Lochhead P, Chan AT (2013) Statins and colorectal cancer. Clin Gastroenterol Hepatol 11:109-118, quiz e113-104
20. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ (2004) The risk of cancer in users of statins. J Clin Oncol 22:2388-2394
21. Kaye JA, Jick H (2004) Statin use and cancer risk in the General Practice Research Database. Br J Cancer 90:635-637
22. Lee J, Lee SH, Hur KY, Woo SY, Kim SW, Kang WK (2012) Statins and the risk of gastric cancer in diabetes patients. BMC Cancer 12:596
23. Vinogradova Y, Coupland C, Hippisley-Cox J (2011) Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer 11:409
24. Lai SW, Liao KF, Lin CY, Lin CL, Sung FC (2013) Statins on the risk of gastric cancer: a population-based observation in Taiwan. Am J Gastroenterol 108:147-149
25. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP Jr, Habel LA (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17:27-36
26. Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, Clopton P, DeMaria AN (2011) Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol 58:530-537
27. Matsushita Y, Sugihara M, Kaburagi J, Ozawa M, Iwashita M, Yoshida S, Saito H, Hattori Y (2010) Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan. Pharmacoepidemiol Drug Saf 19:196-202
28. Sato S, Ajiki W, Kobayashi T, Awata N (2006) Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study. J Epidemiol 16:201-206
29. Chiu HF, Ho SC, Chang CC, Wu TN, Yang CY (2011) Statins are associated with a reduced risk of gastric cancer: a population-based case-control study. Am J Gastroenterol 106:2098-2103
30. Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792-1802
31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
32. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
35. Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Boggild H, Olsen J, Sorensen HT (2005) Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 60:534-542
36. Coogan PF, Smith J, Rosenberg L (2007) Statin use and risk of colorectal cancer. J Natl Cancer Inst 99:32-40
37. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (2012) Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 23:1403-1415
38. Tian W, Zhao Y, Liu S, Li X (2010) Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 19:288-298
39. Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, Caputo S, Grzesk G, Kubica A, Swiatkiewicz I (2013) Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 111:1123-1130
40. Yoon JM, Son KY, Eom CS, Durrance D, Park SM (2013) Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis. World J Gastroenterol 19:936
41. Björkhem-Bergman L, Acimovic J, Torndal U-B, Parini P, Eriksson LC (2010) Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation. Anticancer Res 30:1105-1112
42. Paragh G, Fóris G, Seres I, Karányi Z, Fülöp P, Balogh Z, Kosztáczky B, Teichmann F, Kertai P (2005) Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats. Cancer Lett 222:17-22
43. Acimovic J, Lövgren-Sandblom A, Eriksson LC, Björkhem-Bergman L (2012) The anti-carcinogenic effect of statins in a rat model correlates with levels and synthesis of ubiquinone. Biochem Biophys Res Commun 425:348-352
44. Suh N, Reddy BS, DeCastro A, Paul S, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB (2011) Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prev Res 4:1895-1902
45. Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS (2008) Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer 123:951-957
46. Fritz G (2005) HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Int J Oncol 27:1401-1409
47. Jakobisiak M, Golab J (2003) Potential antitumor effects of statins (Review). Int J Oncol 23:1055-1069
48. Mannello F, Tonti GA (2009) Statins and breast cancer: may matrix metalloproteinase be the missing link. Cancer Investig 27:466-470
49. Solomon KR, Freeman MR (2008) Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19:113-121
50. Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91:143-150
51. Skogastierna C, Johansson M, Parini P, Eriksson M, Eriksson LC, Ekström L, Björkhem-Bergman L (2011) Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development. Biochem Biophys Res Commun 417:1046-1051
52. Alonso DF, Farina HG, Skilton G, Gabri MR, De Lorenzo MS, Gomez DE (1998) Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Breast Cancer Res Treat 50:83-93
53. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE (2005) Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 149:473
54. Endres M (2006) Statins: potential new indications in inflammatory conditions. Atheroscler Suppl 7:31-35